Active Pharm Chemicals Loses Rs 2.17 Crore in API Supply Fraud, 4 Booked

Published On 2025-09-09 13:00 GMT | Update On 2025-09-09 13:00 GMT

Fraud

New Delhi: In a case underlining the growing risks in the pharmaceutical raw material trade, Navsari Rural Police have booked four individuals for allegedly cheating Dahej-based Active Pharm Chemicals LLP of Rs 2.17 crore through a fraudulent procurement deal involving Active Pharmaceutical Ingredients (APIs).

According to the complaint filed by Suresh Jain, proprietor of Active Pharm Chemicals LLP, the accused approached the company between January and June 2025 under the banner of Aviva Life Sciences, Indore. Multiple orders were placed for APIs valued at ₹3.01 crore.

The supplier received only ₹84 lakh as part payment. The remaining ₹1.99 crore was issued through cheques that later bounced, leaving the dues unpaid and exposing the supplier to significant financial losses.

Police have identified the accused as Rajesh Nair, proprietor of Aviva Life Sciences, along with Vikram Jain and Ashish Jain, who were introduced as purchase managers. A fourth individual, Shivji Tiwari, a Mumbai resident, allegedly assisted in setting up the fake firm to facilitate the fraud.

Also Read: Fake WHO, Abbott Emails Used in Over Rs 1.1 Crore Scam on Pharma Executive, 2 Nabbed

Investigators noted that the suspects initially conducted smaller transactions to build trust before defaulting on larger consignments. A police official explained, “The accused gained the supplier’s confidence through regular transactions and then executed the fraud on large consignments.”

Times of India reports that all four have been booked under relevant sections of cheating and fraud, and the investigation is continuing to track the money trail and possible additional links.

This incident comes at a time when several pharma companies and suppliers have flagged increasing instances of financial frauds targeting the trade.

Also Read: Rs 22 Crore Gone in a Click: Pharma Giant Alkem Labs Falls Victim to Cyber Fraud

Article Source : with inputs

Disclaimer: This website is primarily for healthcare professionals. The content here does not replace medical advice and should not be used as medical, diagnostic, endorsement, treatment, or prescription advice. Medical science evolves rapidly, and we strive to keep our information current. If you find any discrepancies, please contact us at corrections@medicaldialogues.in. Read our Correction Policy here. Nothing here should be used as a substitute for medical advice, diagnosis, or treatment. We do not endorse any healthcare advice that contradicts a physician's guidance. Use of this site is subject to our Terms of Use, Privacy Policy, and Advertisement Policy. For more details, read our Full Disclaimer here.

NOTE: Join us in combating medical misinformation. If you encounter a questionable health, medical, or medical education claim, email us at factcheck@medicaldialogues.in for evaluation.

Parthika Patel

Parthika Patel has completed her Graduated B.Pharm from SSR COLLEGE OF PHARMACY and done M.Pharm in Pharmaceutics. She can be contacted at editorial@medicaldialogues.in. Contact no. 011-43720751

Comments Policy

Our comments section is governed by our Comments Policy . By posting comments at Medical Dialogues you automatically agree with our Comments Policy , Terms And Conditions and Privacy Policy .

Active Pharm Chemicals Loses Rs 2.17 Crore in API Supply Fraud, 4 Booked

Similar News

Indian Pharma Market Grows 8.7% in August, Records Rs 20,984 Crore Sales: PharmaTrac

NPPA Clarifies Pharma Data Tender Terms, Technical Presentations on Sept 19

Chemist Body Seeks Transition Period, GST Input Adjustment After Tax Cut, Writes to CM

Strides Pharma Science Singapore arm, Kenox Pharma partner to develop multiple nasal spray products for US

Novartis to buy Tourmaline Bio for USD 1.4 billion

Eli lilly, Circle Pharma ink pact to further enhance AI/ML capabilities

Akums Drugs & Pharma Hormonal manufacturing plant gets EAEU GMP Certification